Re: Prognostic significance of a short sequence insertion in the MCL-1 promoter in chronic lymphocytic leukemia

被引：4
|
作者：
Vargas, RL [1 ]
Felgar, RE [1 ]
Rothberg, PG [1 ]
机构：
[1] Univ Rochester, Med Ctr, Dept Pathol & Lab Med, Rochester, NY 14642 USA
来源：
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2005年 / 97卷 / 14期
关键词：
D O I：
10.1093/jnci/dji119
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1089 / 1090
页数：2
相关论文
共 50 条
  • [31] Targeting Mcl-1 by AMG-176 During Ibrutinib and Venetoclax Therapy in Chronic Lymphocytic Leukemia
    Yi, Xue
    Jain, Nitin
    Iles, LaKesla R.
    Ayres, Mary L.
    Wierda, William G.
    Gandhi, Varsha
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [32] Flavopiridol decreases Mcl-1 and initiates early mitochondrial damage in chronic lymphocytic leukemia (CLL) cells.
    Lucas, David M.
    Hussain, Syed-Rehan A.
    Johnson, Amy J.
    Smith, Lisa L.
    Wagner, Amy J.
    Allison, Jamie M.
    Guster, Sara E.
    Lin, Thomas S.
    Byrd, John C.
    Julian, Mark W.
    Crouser, Elliott D.
    Grever, Michael R.
    BLOOD, 2006, 108 (11) : 595A - 595A
  • [33] Low MCL-1 mRNA expression correlates with prolonged survival in B-cell chronic lymphocytic leukemia
    Veronese, L.
    Tournilhac, O.
    Verrelle, P.
    Davi, F.
    Dighiero, G.
    Chautard, E.
    Veyrat-Masson, R.
    Kwiatkowski, F.
    Goumy, C.
    Vago, P.
    Travade, P.
    Tchirkov, A.
    LEUKEMIA, 2008, 22 (06) : 1291 - 1293
  • [34] Low MCL-1 mRNA expression correlates with prolonged survival in B-cell chronic lymphocytic leukemia
    L Véronèse
    O Tournilhac
    P Verrelle
    F Davi
    G Dighiero
    E Chautard
    R Veyrat-Masson
    F Kwiatkowski
    C Goumy
    P Vago
    P Travade
    A Tchirkov
    Leukemia, 2008, 22 : 1291 - 1293
  • [35] INCIDENCE AND PROGNOSTIC SIGNIFICANCE OF TCL-1 ONCOGENE IN CHRONIC LYMPHOCYTIC LEUKEMIA
    Sachanas, S.
    Rontogianni, D.
    Vassilakopoulos, T.
    Moschogiannis, M.
    Calpadakis, C.
    Yiakoumis, X.
    Kyrtsonis, M.
    Kontopidou, F.
    Dimitrakopoulou, A.
    Levidou, G.
    Pinelopi, K.
    Tsirkinidis, P.
    Papadaki, H.
    Panayiotidis, P.
    Angelopoulou, M.
    Pangalis, G.
    HAEMATOLOGICA, 2013, 98 : 538 - 538
  • [36] Short nucleotide polymorphic insertions in the MCL-1 promoter affect gene expression
    Saxena, Anurag
    Moshynska, Oksana V.
    Moshynskyy, Igor D.
    Neuls, Evan D.
    Qureshi, Tania
    Bosch, Mark
    Voralia, Michael
    Bonham, Keith
    CANCER LETTERS, 2007, 251 (01) : 114 - 131
  • [37] Short nucleotide insertions in the MCL-1 promoter affect its gene expression
    Moshynska, O
    Moshynskyy, I
    Bosch, M
    Qureshi, T
    Saxena, A
    BLOOD, 2005, 106 (11) : 172B - 172B
  • [38] The prognostic significance of cytopenia in chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL)
    Zent, Clive S.
    Ding, Wei
    Giordano, Karin F.
    Schwager, Susan M.
    Shanafelt, Tait D.
    Reinalda, Megan S.
    Hoyer, James D.
    Jelinek, Diane F.
    Tschumper, Renee C.
    Bowen, Deborah A.
    Call, Timothy G.
    Kay, Neil E.
    Slager, Susan L.
    BLOOD, 2007, 110 (11) : 229A - 230A
  • [39] Macrophages confer survival signals via CCR1-dependent translational MCL-1 induction in chronic lymphocytic leukemia
    van Attekum, M. H. A.
    Terpstra, S.
    Slinger, E.
    von Lindern, M.
    Moerland, P. D.
    Jongejan, A.
    Kater, A. P.
    Eldering, E.
    ONCOGENE, 2017, 36 (26) : 3651 - 3660
  • [40] The prognostic significance of interphase cytogenetic abnormalities in chronic lymphocytic leukemia
    Nedeva, A.
    Naseva, E.
    Kindekov, I.
    Petkova, N.
    Nikolov, I.
    Raynov, J.
    ARCHIVES OF HELLENIC MEDICINE, 2018, 35 (04): : 520 - 526
12345